P809: BASELINE CHARACTERISTICS IDENTIFYING PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IDECABTAGENE VICELEUCEL (IDE-CEL; BB2121) WHO ARE AT RISK FOR SEVERE/REFRACTORY INFLAMMATORY ADVERSE EVENTS

Detalles Bibliográficos
Autores principales: Mashadi-Hossein, Afshin, Rytlewski, Julie, Shamsuzzaman, MD, Basudhar, Debashree, Takhar, Mandeep, Kostic, Ana, Campbell, Timothy B., Manier, Salomon, Lin, Yi, Martin, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430627/
http://dx.doi.org/10.1097/01.HS9.0000970140.10042.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430627/
http://dx.doi.org/10.1097/01.HS9.0000970140.10042.07

Ejemplares similares